ORCA
Online Research @ CardiffÂ
Browse by Current Cardiff authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 2.
Russell, Nigel H., Othman, Jad, Cumming, Oliver Sebastian, Thomas, Abin  ORCID: https://orcid.org/0000-0002-8283-6762, Tedjaseputra, Aditya, Potter, Nicola, Jovanovic, Jelena, Gilkes, Amanda Frances, Batten, Leona, Canham, Joanna ORCID: https://orcid.org/0000-0003-3482-0990, Hinson, Emily L., Runglall, Manohursingh, Aucken, Phoebe, Kottaridis, Panagiotis, Cavenagh, James Durrell, Arnold, Claire, Freeman, Sylvie D., Dennis, Mike, Knapper, Steven and Dillon, Richard James
2025.
Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3 mutated AML.
Blood Advances
, bloodadvances.2025017244.
10.1182/bloodadvances.2025017244
|
|
|
Russell, Nigel, Cumming, Oliver, Othman, Jad, Dillon, Richard, Potter, Nicola, Wilhelm-Benartzi, Charlotte ORCID: https://orcid.org/0000-0003-4927-6158, Jovanovic, Jelena, Gilkes, Amanda, Batten, Leona, Canham, Joanna ORCID: https://orcid.org/0000-0003-3482-0990, Laura Hinson, Emily, Kottaridis, Panagiotis, Cavenagh, Jamie, Arnold, Claire, Dennis, Mike and Knapper, Steven ORCID: https://orcid.org/0000-0002-6405-4441
2023.
P484: Gemtuzumab-based induction chemotherapy combined with midostaurin for FLT3 mutated AML. Updated toxicity and interim survival analysis from the NCRI AML19v2 "Midotarg" Pilot Trial.
HemaSphere
7
(S3)
, e13145db.
10.1097/01.HS9.0000968844.13145.db
|
|
|